Mymetics Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 11/06/2017
Contact Info
  • co Mymetics S.A.
  • Biopole
  • Route de la Corniche, 4
  • Epalinges 1066
  • Switzerland

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0000927761
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 1994
Employees 9 a/o Dec 31, 2016
Company Officers/Contacts
Ronald Kempers President, CEO
Sylvain Fleury CSO
Toon Stegmann Chief Scientific Officer
Carmelina Mahrer Director, Fin.
Company Directors
Ulrich Burkhard
Thomas Staehelin
Ernest M. Stern
Company Notes
  • Formerly=ICHOR Corp. until 7-01
  • Formerly=PDG Remediation, Inc. until 1-97
Service Providers
Accounting/Auditing Firm
Peterson Sullivan LLP
601 Union St.
Suite 2300
Seattle, WA, 98101
United States

Legal Counsel
Culhane Meadows PLLC
1101 Pennsylvania Avenue, N.W
Suite 600
Washington, DC, 20004
United States

Investor Relations Firm
Dynamics Group SA
Rue de Caroubiers 21
CH 1227 Carouge

MYMX Security Details
Share Structure
Market Value1 $6,227,031 a/o Dec 15, 2017
Authorized Shares 1,000,000,000 a/o Mar 29, 2016
Outstanding Shares 303,757,622 a/o Aug 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 91,064,968 a/o Mar 29, 2016
Par Value 0.01
Transfer Agent(s) Verified by Transfer Agent
Interwest Transfer Co., Inc.
Shareholders of Record 650 a/o Mar 30, 2017
Short Selling Data
Short Interest 7,284 (100%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security